Pressure BioSciences Inc.’s (PBIO) New Products and Enhanced Sales Capabilities Drive Plans for Banner 2018

April 10, 2018 11:45:43
  • Record product sales growth reported for fourth quarter and full year 2017
  • Company has over 300 of its ultra-high pressure instruments in research labs worldwide
  • 2017 revenue exceeded $2.2 million with just one field sales rep; company’s field sales force expanded to five with recent hires
  • December 2017 acquisition of high pressure IP allows company to enter the biologics contract research services sector
  • Newly-issued patents in Ultra Shear Technology (UST) address broad markets for stable, water-soluble nanoemulsions, including cannabinoids

As scientific researchers who work with cellular material seek to uncover new potential for creating vaccines and drugs, counteracting harmful chemicals and making the therapeutic properties of nutraceuticals and pharmaceuticals more effective, Pressure BioSciences Inc. (OTCQB: PBIO) is watching its development of pressure-based laboratory tools and related consumable products gain a growing worldwide following. Pressure BioSciences’ products are based on the notion that using high pressures to break open cells in order to tap their potential for medicinal and therapeutic uses is a more productive, beneficial way of extracting the biomolecules inside, as compared to traditional methods of ‘beating up’ cells that are commonly employed in research. The company expects recent product development, company acquisitions and personnel decisions to drive it toward a banner year in 2018.

“We have about 300 instruments already placed in research labs all over the world. These instruments generate pressures from levels of several hundred pounds per square inch (“psi”) all the way up to, believe it or not, 90,000 psi,” CEO Ric Schumacher said in a March interview with…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office